<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Phyllodes tumor</title><meta name="description" content="Phyllodes tumors (from Greek: phyllon, meaning &quot;leaf&quot;) are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="Cystosarcoma phyllodes, Phyllodes tumour, Phylloides tumor"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Phyllodes_tumor"/><meta property="og:title" content="Phyllodes tumor"/><meta property="og:description" content="Phyllodes tumors (from Greek: phyllon, meaning &quot;leaf&quot;) are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization..."/><meta property="og:url" content="https://grokipedia.com/page/Phyllodes_tumor"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Phyllodes tumor"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.913Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Phyllodes tumor"/><meta name="twitter:description" content="Phyllodes tumors (from Greek: phyllon, meaning &quot;leaf&quot;) are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="e7f29d36600c9c67dcc016b696396255-983b63e316b7ed36-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=e7f29d36600c9c67dcc016b696396255,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.5563879928488418,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>⌘</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#phyllodes-tumor" class="transition-opacity hover:opacity-100 opacity-50">Phyllodes tumor</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#phyllodes-tumor-1" class="transition-opacity hover:opacity-100 opacity-50">Phyllodes Tumor</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#signs-and-symptoms" class="transition-opacity hover:opacity-100 opacity-50">Signs and symptoms</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#phyllodes-tumors" class="transition-opacity hover:opacity-100 opacity-50">Phyllodes tumors</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#causes" class="transition-opacity hover:opacity-100 opacity-50">Causes</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#phyllodes-tumor-mechanism" class="transition-opacity hover:opacity-100 opacity-50">Phyllodes Tumor Mechanism</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism" class="transition-opacity hover:opacity-100 opacity-50">Mechanism</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnosis" class="transition-opacity hover:opacity-100 opacity-50">Diagnosis</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnostic-techniques" class="transition-opacity hover:opacity-100 opacity-50">Diagnostic techniques</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#classification" class="transition-opacity hover:opacity-100 opacity-50">Classification</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prevention-and-screening" class="transition-opacity hover:opacity-100 opacity-50">Prevention and screening</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#treatment" class="transition-opacity hover:opacity-100 opacity-50">Treatment</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prognosis" class="transition-opacity hover:opacity-100 opacity-50">Prognosis</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#epidemiology" class="transition-opacity hover:opacity-100 opacity-50">Epidemiology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="phyllodes-tumor" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Phyllodes tumor<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Phyllodes tumors</strong> (from Greek: <em>phyllon</em>, meaning &quot;leaf&quot;) are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> They account for less than 1% of all breast neoplasms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> They were previously termed <strong>cystosarcoma phyllodes</strong>, coined by Johannes Müller in 1838, before being renamed to <strong>phyllodes tumor</strong> by the World Health Organization in 2003.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> <em>Phyllon</em>, which means &quot;leaf&quot; in Greek, describes the unique papillary projections characteristic of phyllodes tumors on histology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Phyllodes tumors are classified as benign, borderline, or malignant based on histologic features.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Diagnosis is made via core-needle biopsy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Treatment is typically surgical resection with wide margins (&gt;1 cm), due to their propensity to recur.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h1 id="phyllodes-tumor-1" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Phyllodes Tumor<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="signs-and-symptoms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Signs and symptoms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Phyllodes tumors typically present as a firm, mobile, and palpable mass that is painless in nature.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> On physical examination, the mass can demonstrate a smooth or nodular texture depending on its size.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> In addition, larger masses can stretch the overlying breast tissue leading to nipple retraction, chest wall fixation, and in advanced cases, ulceration from pressure <span class="inline text-[1em] leading-7">necrosis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Rarely, bloody nipple discharge may occur due to infarction within the tumor. Larger tumors may also cause distension of superficial veins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Phyllodes tumors can grow to a variety of sizes, ranging from 0.8 to 40 cm, with the average tumor growing to between 4 and 8 cm.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Their growth can be slow, rapid, or demonstrate alternating growth patterns.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> A notable feature, however, is that their growth rarely regresses, a distinguishing feature from <span class="inline text-[1em] leading-7">fibroadenomas</span> which tend to change in size based on a female&#x27;s menstrual cycle.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h1 id="phyllodes-tumors" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Phyllodes tumors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="causes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Causes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The exact etiology of phyllodes tumors is unknown.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> They may represent a progression from preexisting fibroadenomas.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Possible growth stimuli include trauma, pregnancy, increased estrogen activity, and lactation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_64abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Genetically, phyllodes tumors occur at higher incidence in patients with Li-Fraumeni syndrome.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Rare cases in males are often associated with gynecomastia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h1 id="phyllodes-tumor-mechanism" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Phyllodes Tumor Mechanism<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="mechanism" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Mechanism<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The pathogenesis behind the development of a phyllodes tumor is not well-defined.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Some theories suggest a genetic cause while other literature supports the involvement of hormone and growth factor receptors, cell signal transduction pathways, and cell cycle markers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> Certain receptors include estrogen/progesterone, glucocorticoid, and HER2.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_75qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> The most well-studied cell signal transduction pathway includes the Wnt pathway, which is a highly conserved genetic pathway between species.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> In the Wnt pathway, stabilized beta-catenin translocates to the nucleus and promotes transcription of target genes such as c-myc, c-jun, Fra-1, and cyclin D1, which contribute to cell proliferation. Dysregulation of the Wnt pathway, often through mutations in components like APC or beta-catenin, results in uncontrolled growth characteristic of phyllodes tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In addition, vascular factors promoting angiogenesis have been shown to further promote growth of these breast masses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_26abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> These proteins include vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1α (HIF-1α), platelet-derived growth factor (PDGF), endothelin-1, and nitric oxide synthase.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> The increased expression of these angiogenic factors reflects the increased angiogenesis seen in higher grade phyllodes tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_66abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Genes that have been associated with a higher incidence of phyllodes tumors include Mediator Complex Subunit 12 (MED12) exon 2 (~70-80% of cases), Telomerase Reverse Transcriptase (TERT) promoter (~50%), and Retinoic Acid Receptor Alpha (RARA) (~20-30%); these genes regulate transcription, telomere maintenance, and differentiation, respectively, and support a clonal stromal origin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_26qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> Malignant phyllodes tumors often harbor additional alterations, such as EGFR amplification and PIK3CA mutations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_56qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Recent studies indicate that phyllodes tumor development arises from dysregulated epithelial-stromal interactions, driven by genetic alterations and pathway activations (including Wnt and angiogenesis) that promote stromal proliferation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_27abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<h2 id="diagnosis" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Diagnosis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="diagnostic-techniques" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Diagnostic techniques<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Radiographical imaging</span> is the first-line test for identifying a phyllodes tumor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Despite their propensity to grow rapidly and deform the overlying breast tissue, approximately 20% of phyllodes tumors can present as a nonpalpable mass on screening mammography.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Other imaging tools used to assess the size and spread of a phyllodes tumor include <span class="inline text-[1em] leading-7">ultrasound</span> and <span class="inline text-[1em] leading-7">magnetic resonance imaging</span> (MRI).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> None of these imaging tools are definitive tests for differentiating a phyllodes tumor from a benign <span class="inline text-[1em] leading-7">fibroadenoma</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> Phyllodes tumors can only be diagnosed <span class="inline text-[1em] leading-7">histologically</span>, as they tend to have many overlapping features with other breast masses on physical examination and radiological imaging.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A <span class="inline text-[1em] leading-7">core needle biopsy</span> is the primary tool used to provide a definitive diagnosis for phyllodes tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Other biopsy techniques include <span class="inline text-[1em] leading-7">fine-needle aspiration</span> and excisional biopsy; however, fine-needle aspiration is less reliable due to cytologic overlap with fibroadenoma.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Following <span class="inline text-[1em] leading-7">biopsy</span>, histological and gross examination is performed which helps clinicians better grade and classify the phyllodes tumor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<h3 id="classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Phyllodes tumors are part of a group of breast diseases called cellular <span class="inline text-[1em] leading-7">fibroepithelial lesions</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> This term incorporates a spectrum of diseases ranging from a benign <span class="inline text-[1em] leading-7">fibroadenoma</span> to a malignant phyllodes tumor, with numerous variants in between.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> They are classified by <span class="inline text-[1em] leading-7">ICD-O</span>, not by <span class="inline text-[1em] leading-7">MeSH</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Phyllodes tumors may be considered <span class="inline text-[1em] leading-7">benign</span>, <span class="inline text-[1em] leading-7">borderline</span>, or <span class="inline text-[1em] leading-7">malignant</span> depending upon their histological features, including stromal cellularity, infiltration of the epithelial-stromal interface, and mitotic activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Malignant phyllodes tumors have a propensity to metastasize and grow quickly, and are treated with consideration of their sarcomatous potential.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> A large case series from the MD Anderson Cancer Center reported the incidence of each type of phyllodes tumor as benign (58%), borderline (12%), and malignant (30%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_caqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Malignant phyllodes tumors can behave similarly to <span class="inline text-[1em] leading-7">sarcomas</span> leading to development of <span class="inline text-[1em] leading-7">blood-borne</span> metastases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Distant metastases are rare, occurring in less than 5% of cases overall but in approximately 15-20% of malignant cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> The most common site for distant metastases is the lung, followed by bone and abdominal viscera.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ababav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> In more insidious cases, the <span class="inline text-[1em] leading-7">parotid</span> region has also been described in literature.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ebabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>









































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Histopathologic classification</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Benign</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Borderline</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Malignant</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Margin</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pushing</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pushing or irregular</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Infiltrating</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stromal atypia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Minimal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Moderate</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Severe</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stromal cellularity</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Mild</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Moderate</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Marked</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Mitoses per 10 </span><span class="inline text-[1em] leading-7">HPF</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">≤4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5 to 9</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">≥10</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stromal overgrowth</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Absent</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Focal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Present</span></td></tr></tbody></table></div>
<h2 id="prevention-and-screening" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Prevention and screening<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">There are no evidence-based recommendations for specific screening or preventive measures for the early detection of phyllodes tumors, due to their rarity and lack of known modifiable risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In patients with a prior history of a phyllodes tumor, follow-up recommendations are determined on a case-by-case basis depending on the grade and stage of the treated tumor, typically involving clinical breast examinations and imaging (e.g., mammography or ultrasound) every 6–12 months for the first 2–5 years, then annually thereafter, tailored to recurrence risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Patients who have not had a mastectomy should continue regular breast cancer screening based on the recommendations by the United States Preventive Services Task Force, which as of 2024 advises biennial screening mammography for women aged 40 to 74 at average risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<h1 id="treatment" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Treatment<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Treatment for phyllodes tumors varies by histologic grade (benign, borderline, or malignant). The primary treatment is surgical excision aiming for negative margins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> For benign tumors, simple excision with negative margins is often sufficient, without requiring wide margins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> For borderline and malignant tumors, wide local excision with margins of at least 1 cm is traditionally recommended to minimize local recurrence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Mastectomy may be considered for large or multifocal tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chemotherapy has a limited role and is typically reserved for metastatic disease, with no proven benefit in adjuvant settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Adjuvant radiation therapy after breast-conserving surgery with negative margins may reduce local recurrence rates in borderline and malignant tumors, though it does not improve survival.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The risk of local recurrence or metastases relates to the tumor&#x27;s histologic grade and mitotic activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Despite appropriate surgery, incomplete margins occur in a substantial proportion of cases (approximately 28%), often necessitating re-excision.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<h2 id="prognosis" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Prognosis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The prognosis of phyllodes tumor is good with an overall 87% 10-year survival rate.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Local recurrence rates vary by grade: 10–17% for benign, 14–25% for borderline, and 23–30% for malignant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> After wide-margin surgical excision, 98.7% of benign phyllodes tumors and 80% of borderline were cured.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> In rare cases where the tumor has metastasized (less than 5% overall), the prognosis is poor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> This most commonly occurs in cases of malignant grade phyllodes tumor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<h2 id="epidemiology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Epidemiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Phyllodes tumors account for less than 1% of all breast neoplasms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> They primarily occur in adult women, with very few examples reported in adolescents. The annual incidence is approximately 2.5 cases per million women, with higher rates observed among Hispanic and Asian women.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> Incidence is most common between the ages of 40 and 50, prior to the onset of <span class="inline text-[1em] leading-7">menopause</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Phyllodes tumors typically present about 15 years later than <span class="inline text-[1em] leading-7">fibroadenoma</span>, a common differential diagnosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Younger women have a higher chance of having a benign phyllodes tumor, while older women are more likely to have higher-grade tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hasdemir S, Tolunay Ş, Özşen M, Gökgöz MŞ (January 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases&quot;</a>. <em>European Journal of Breast Health</em>. <strong>16</strong> (1): 32–38. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.5152%2Fejbh.2019.4709" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.5152/ejbh.2019.4709</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6939715</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31912011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31912011</a>.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Limaiem F, Kashyap S (2022). <a href="https://www.ncbi.nlm.nih.gov/books/NBK541138/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Phyllodes Tumor Of The Breast</em></a>. Treasure Island (FL): StatPearls Publishing. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31082182" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31082182</a>. Retrieved 2023-01-18. <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite book}}</code>: <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">|work=</code> ignored (help)</span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Konstantakos AK, Graham DJ (September 2003). &quot;Cystosarcoma phyllodes tumors in men&quot;. <em>The American Surgeon</em>. <strong>69</strong> (9): 808–811. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F000313480306900916" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/000313480306900916</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/14509333" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14509333</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:26206134" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26206134</a>.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhou ZR, Wang CC, Yang ZZ, Yu XL, Guo XM (November 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence&quot;</a>. <em>Journal of Thoracic Disease</em>. <strong>8</strong> (11): 3361–3368. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.21037%2Fjtd.2016.11.03" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.21037/jtd.2016.11.03</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5179374</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28066617" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28066617</a>.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H (September 2003). <a href="https://doi.org/10.1001%2Farchsurg.138.9.987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma&quot;</a>. <em>Archives of Surgery</em>. <strong>138</strong> (9): 987–990. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchsurg.138.9.987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archsurg.138.9.987</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12963656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12963656</a>.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Khan SA, Badve S (April 2001). &quot;Phyllodes tumors of the breast&quot;. <em>Current Treatment Options in Oncology</em>. <strong>2</strong> (2): 139–147. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs11864-001-0056-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s11864-001-0056-y</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12057132" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12057132</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:34616186" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">34616186</a>.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. (February 2008). &quot;Phyllodes tumor of the breast&quot;. <em>International Journal of Radiation Oncology, Biology, Physics</em>. <strong>70</strong> (2): 492–500. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.ijrobp.2007.06.059" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.ijrobp.2007.06.059</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17931796" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17931796</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hartmann TC, Hanna MW (October 2022). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Delayed Conversion of a Fibroadenoma Into a Large Phyllodes Tumor: A Case Report&quot;</a>. <em>Cureus</em>. <strong>14</strong> (10): e30795. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7759%2Fcureus.30795" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7759/cureus.30795</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9701494</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/36447717" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36447717</a>.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Karim, Rooshdiya Z.; Scolyer, Richard A.; Tse, Gary M.; Tan, Puay-Hoon; Putti, Thomas C.; Lee, C. Soon (February 2009). &quot;Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours&quot;. <em>Pathology</em>. <strong>41</strong> (2): 105–117. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F00313020802579342" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/00313020802579342</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0031-3025" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0031-3025</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19152185" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19152185</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:34470088" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">34470088</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sim, Yirong; Ng, Gwendolene Xin Pei; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Wong, Suet Far; Liu, Wei; Guan, Peiyong; Nagarajan, Sanjanaa; Ng, Wai Yee; Thike, Aye Aye; Lim, Jeffrey Chun Tatt; Nasir, Nur Diyana Binte Md; Tan, Veronique Kiak Mien; Madhukumar, Preetha; Yong, Wei Sean (2019-10-23). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions&quot;</a>. <em>BMC Medical Genomics</em>. <strong>12</strong> (1): 142. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2Fs12920-019-0588-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/s12920-019-0588-2</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1755-8794" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1755-8794</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6813086</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31647027" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31647027</a>.</span></div></li><li id="https://academic.oup.com/oncolo/article/29/12/1024/7742815" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/oncolo/article/29/12/1024/7742815" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/oncolo/article/29/12/1024/7742815</a></span></div></li><li id="https://ejbc.kr/DOIx.php?id=10.4048/jbc.2024.0284" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ejbc.kr/DOIx.php?id=10.4048/jbc.2024.0284" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ejbc.kr/DOIx.php?id=10.4048/jbc.2024.0284</a></span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Boutas, Ioannis; Kontogeorgi, Adamandia; Dimas, Dionysios; Koufopoulos, Nektarios; Genitsaridi, Sofia-Maria; Sitara, Kyparissia; Kalantaridou, Sophia; Dimitrakakis, Constantine (October 2022). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Local recurrence for phyllodes tumours of the breast: Systematic review and meta-analysis&quot;</a>. <em>Oncology Letters</em>. <strong>24</strong> (4): 353. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3892%2Fol.2022.13473" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3892/ol.2022.13473</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1792-1082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1792-1082</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9478605</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/36168312" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36168312</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Macdonald, O. Kenneth; Lee, Christopher M.; Tward, Jonathan D.; Chappel, Craig D.; Gaffney, David K. (2006-11-01). <a href="https://doi.org/10.1002%2Fcncr.22228" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program&quot;</a>. <em>Cancer</em>. <strong>107</strong> (9): 2127–2133. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fcncr.22228" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/cncr.22228</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0008-543X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0008-543X</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16998937" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16998937</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:35411155" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">35411155</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uptodate.com/contents/phyllodes-tumors-of-the-breast" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;UpToDate&quot;</a>. <em><a href="http://www.uptodate.com" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">www.uptodate.com</a></em>. Retrieved 2023-01-26.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Deen SA, McKee GT, Kissin MW (February 1999). &quot;Differential cytologic features of fibroepithelial lesions of the breast&quot;. <em>Diagnostic Cytopathology</em>. <strong>20</strong> (2): 53–56. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F%28SICI%291097-0339%28199902%2920%3A2%3C53%3A%3AAID-DC1%3E3.0.CO%3B2-T" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/(SICI)1097-0339(199902)20:2&lt;53::AID-DC1&gt;3.0.CO;2-T</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9951596" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9951596</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:21831164" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21831164</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. (January 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Phyllodes tumours of the breast: a consensus review&quot;</a>. <em>Histopathology</em>. <strong>68</strong> (1): 5–21. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fhis.12876" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/his.12876</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5027876</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26768026" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26768026</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Majeski, James; Stroud, Jason (2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Malignant phyllodes tumors of the breast: a study in clinical practice&quot;</a>. <em>International Surgery</em>. <strong>97</strong> (2): 95–98. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.9738%2FCC79.1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.9738/CC79.1</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/2520-2456" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2520-2456</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3723204</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23102073" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23102073</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang, John Z.; Gu, Mai (2003). &quot;Malignant phyllodes tumor of the breast metastatic to the parotid gland diagnosed by fine needle aspiration biopsy. A case report&quot;. <em>Acta Cytologica</em>. <strong>47</strong> (2): 253–258. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1159%2F000326512" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1159/000326512</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0001-5547" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0001-5547</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12685197" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12685197</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:3364081" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3364081</a>.</span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK541138/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK541138/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK541138/</a></span></div></li><li id="https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf</a></span></div></li><li id="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening</a></span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Barth RJ, Wells WA, Mitchell SE, Cole BF (August 2009). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors&quot;</a>. <em>Annals of Surgical Oncology</em>. <strong>16</strong> (8): 2288–2294. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1245%2Fs10434-009-0489-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1245/s10434-009-0489-2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5053421</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19424757" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19424757</a>.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. (2011). <a href="https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Management of phyllodes breast tumors&quot;</a>. <em>The Breast Journal</em>. <strong>17</strong> (2): 129–137. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1524-4741.2010.01045.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21251125" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21251125</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:7074922" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7074922</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Reinfuss, M.; Mituś, J.; Duda, K.; Stelmach, A.; Ryś, J.; Smolak, K. (1996-03-01). <a href="https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases&quot;</a>. <em>Cancer</em>. <strong>77</strong> (5): 910–916. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/(sici)1097-0142(19960301)77:5&lt;910::aid-cncr16&gt;3.0.co;2-6</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0008-543X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0008-543X</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8608483" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8608483</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:46154369" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">46154369</a>.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bernstein, L.; Deapen, D.; Ross, R. K. (1993-05-15). <a href="https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast&quot;</a>. <em>Cancer</em>. <strong>71</strong> (10): 3020–3024. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/1097-0142(19930515)71:10&lt;3020::aid-cncr2820711022&gt;3.0.co;2-g</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0008-543X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0008-543X</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8387873" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8387873</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:21014296" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21014296</a>.</span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Phyllodes_tumor" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl" id="_R_" async=""></script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Phyllodes_tumor\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Phyllodes_tumor\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Phyllodes_tumor\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T2cf4,"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"# Phyllodes tumor\n\n**Phyllodes tumors** (from Greek: _phyllon_, meaning \"leaf\") are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed **cystosarcoma phyllodes**, coined by Johannes Müller in 1838, before being renamed to **phyllodes tumor** by the World Health Organization in 2003.[3] _Phyllon_, which means \"leaf\" in Greek, describes the unique papillary projections characteristic of phyllodes tumors on histology.[1] Phyllodes tumors are classified as benign, borderline, or malignant based on histologic features.[5] Diagnosis is made via core-needle biopsy.[4] Treatment is typically surgical resection with wide margins (\u003e1 cm), due to their propensity to recur.[5]\n# Phyllodes Tumor\n\n## Signs and symptoms\n\nPhyllodes tumors typically present as a firm, mobile, and palpable mass that is painless in nature.[5] On physical examination, the mass can demonstrate a smooth or nodular texture depending on its size.[3] In addition, larger masses can stretch the overlying breast tissue leading to nipple retraction, chest wall fixation, and in advanced cases, ulceration from pressure [necrosis](Necrosis \"Necrosis\").[6] Rarely, bloody nipple discharge may occur due to infarction within the tumor. Larger tumors may also cause distension of superficial veins.[5]\n\nPhyllodes tumors can grow to a variety of sizes, ranging from 0.8 to 40 cm, with the average tumor growing to between 4 and 8 cm.[7] Their growth can be slow, rapid, or demonstrate alternating growth patterns.[5] A notable feature, however, is that their growth rarely regresses, a distinguishing feature from [fibroadenomas](Fibroadenoma \"Fibroadenoma\") which tend to change in size based on a female's menstrual cycle.[8]\n# Phyllodes tumors\n\n## Causes\n\nThe exact etiology of phyllodes tumors is unknown.[5] They may represent a progression from preexisting fibroadenomas.[5] Possible growth stimuli include trauma, pregnancy, increased estrogen activity, and lactation.[5] Genetically, phyllodes tumors occur at higher incidence in patients with Li-Fraumeni syndrome.[5] Rare cases in males are often associated with gynecomastia.[5]\n# Phyllodes Tumor Mechanism\n\n## Mechanism\n\nThe pathogenesis behind the development of a phyllodes tumor is not well-defined.[9] Some theories suggest a genetic cause while other literature supports the involvement of hormone and growth factor receptors, cell signal transduction pathways, and cell cycle markers.[9][10] Certain receptors include estrogen/progesterone, glucocorticoid, and HER2.[9] The most well-studied cell signal transduction pathway includes the Wnt pathway, which is a highly conserved genetic pathway between species.[9] In the Wnt pathway, stabilized beta-catenin translocates to the nucleus and promotes transcription of target genes such as c-myc, c-jun, Fra-1, and cyclin D1, which contribute to cell proliferation. Dysregulation of the Wnt pathway, often through mutations in components like APC or beta-catenin, results in uncontrolled growth characteristic of phyllodes tumors.[9]\n\nIn addition, vascular factors promoting angiogenesis have been shown to further promote growth of these breast masses.[9] These proteins include vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1α (HIF-1α), platelet-derived growth factor (PDGF), endothelin-1, and nitric oxide synthase.[9] The increased expression of these angiogenic factors reflects the increased angiogenesis seen in higher grade phyllodes tumors.[9]\n\nGenes that have been associated with a higher incidence of phyllodes tumors include Mediator Complex Subunit 12 (MED12) exon 2 (~70-80% of cases), Telomerase Reverse Transcriptase (TERT) promoter (~50%), and Retinoic Acid Receptor Alpha (RARA) (~20-30%); these genes regulate transcription, telomere maintenance, and differentiation, respectively, and support a clonal stromal origin.[10] Malignant phyllodes tumors often harbor additional alterations, such as EGFR amplification and PIK3CA mutations.[](https://academic.oup.com/oncolo/article/29/12/1024/7742815)[](https://ejbc.kr/DOIx.php?id=10.4048/jbc.2024.0284)\n\nRecent studies indicate that phyllodes tumor development arises from dysregulated epithelial-stromal interactions, driven by genetic alterations and pathway activations (including Wnt and angiogenesis) that promote stromal proliferation.[9]\n## Diagnosis\n\n### Diagnostic techniques\n\n[Radiographical imaging](Radiology \"Radiology\") is the first-line test for identifying a phyllodes tumor.[11] Despite their propensity to grow rapidly and deform the overlying breast tissue, approximately 20% of phyllodes tumors can present as a nonpalpable mass on screening mammography.[12] Other imaging tools used to assess the size and spread of a phyllodes tumor include [ultrasound](Ultrasound \"Ultrasound\") and [magnetic resonance imaging](Magnetic_resonance_imaging \"Magnetic resonance imaging\") (MRI).[11] None of these imaging tools are definitive tests for differentiating a phyllodes tumor from a benign [fibroadenoma](Fibroadenoma \"Fibroadenoma\").[13] Phyllodes tumors can only be diagnosed [histologically](Histology \"Histology\"), as they tend to have many overlapping features with other breast masses on physical examination and radiological imaging.[11]\n\nA [core needle biopsy](Biopsy \"Biopsy\") is the primary tool used to provide a definitive diagnosis for phyllodes tumors.[11] Other biopsy techniques include [fine-needle aspiration](Fine-needle_aspiration \"Fine-needle aspiration\") and excisional biopsy; however, fine-needle aspiration is less reliable due to cytologic overlap with fibroadenoma.[4] Following [biopsy](Biopsy \"Biopsy\"), histological and gross examination is performed which helps clinicians better grade and classify the phyllodes tumor.[11]\n\n### Classification\n\nPhyllodes tumors are part of a group of breast diseases called cellular [fibroepithelial lesions](Fibroepithelial_neoplasm \"Fibroepithelial neoplasm\").[8] This term incorporates a spectrum of diseases ranging from a benign [fibroadenoma](Fibroadenoma \"Fibroadenoma\") to a malignant phyllodes tumor, with numerous variants in between.[14] They are classified by [ICD-O](ICD-O \"ICD-O\"), not by [MeSH](Medical_Subject_Headings \"Medical Subject Headings\").[14]\n\nPhyllodes tumors may be considered [benign](Benign_tumor \"Benign tumor\"), [borderline](Borderline_tumor \"Borderline tumor\"), or [malignant](Malignant_tumor \"Malignant tumor\") depending upon their histological features, including stromal cellularity, infiltration of the epithelial-stromal interface, and mitotic activity.[15] Malignant phyllodes tumors have a propensity to metastasize and grow quickly, and are treated with consideration of their sarcomatous potential.[15] A large case series from the MD Anderson Cancer Center reported the incidence of each type of phyllodes tumor as benign (58%), borderline (12%), and malignant (30%).[16]\n\nMalignant phyllodes tumors can behave similarly to [sarcomas](Sarcoma \"Sarcoma\") leading to development of [blood-borne](Blood-borne_disease \"Blood-borne disease\") metastases.[16] Distant metastases are rare, occurring in less than 5% of cases overall but in approximately 15-20% of malignant cases.[15] The most common site for distant metastases is the lung, followed by bone and abdominal viscera.[5] In more insidious cases, the [parotid](Parotid_gland \"Parotid gland\") region has also been described in literature.[18]\n\n| Histopathologic classification[15] | Benign | Borderline | Malignant |\n|------------------------------------|--------|------------|-----------|\n| Margin | Pushing | Pushing or irregular | Infiltrating |\n| Stromal atypia | Minimal | Moderate | Severe |\n| Stromal cellularity | Mild | Moderate | Marked |\n| Mitoses per 10 [HPF](High_power_field \"High power field\") | ≤4 | 5 to 9 | ≥10 |\n| Stromal overgrowth | Absent | Focal | Present |\n## Prevention and screening\n\nThere are no evidence-based recommendations for specific screening or preventive measures for the early detection of phyllodes tumors, due to their rarity and lack of known modifiable risk factors.[](https://www.ncbi.nlm.nih.gov/books/NBK541138/)\n\nIn patients with a prior history of a phyllodes tumor, follow-up recommendations are determined on a case-by-case basis depending on the grade and stage of the treated tumor, typically involving clinical breast examinations and imaging (e.g., mammography or ultrasound) every 6–12 months for the first 2–5 years, then annually thereafter, tailored to recurrence risk.[](https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf)\n\nPatients who have not had a mastectomy should continue regular breast cancer screening based on the recommendations by the United States Preventive Services Task Force, which as of 2024 advises biennial screening mammography for women aged 40 to 74 at average risk.[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening)\n# Treatment\n\nTreatment for phyllodes tumors varies by histologic grade (benign, borderline, or malignant). The primary treatment is surgical excision aiming for negative margins.[15] For benign tumors, simple excision with negative margins is often sufficient, without requiring wide margins.[15] For borderline and malignant tumors, wide local excision with margins of at least 1 cm is traditionally recommended to minimize local recurrence.[15] Mastectomy may be considered for large or multifocal tumors.[15]\n\nChemotherapy has a limited role and is typically reserved for metastatic disease, with no proven benefit in adjuvant settings.[15] Adjuvant radiation therapy after breast-conserving surgery with negative margins may reduce local recurrence rates in borderline and malignant tumors, though it does not improve survival.[15][24]\n\nThe risk of local recurrence or metastases relates to the tumor's histologic grade and mitotic activity.[15] Despite appropriate surgery, incomplete margins occur in a substantial proportion of cases (approximately 28%), often necessitating re-excision.[23]\n## Prognosis\n\nThe prognosis of phyllodes tumor is good with an overall 87% 10-year survival rate.[5] Local recurrence rates vary by grade: 10–17% for benign, 14–25% for borderline, and 23–30% for malignant.[5] After wide-margin surgical excision, 98.7% of benign phyllodes tumors and 80% of borderline were cured.[25] In rare cases where the tumor has metastasized (less than 5% overall), the prognosis is poor.[5] This most commonly occurs in cases of malignant grade phyllodes tumor.[5]\n## Epidemiology\n\nPhyllodes tumors account for less than 1% of all breast neoplasms.[2] They primarily occur in adult women, with very few examples reported in adolescents. The annual incidence is approximately 2.5 cases per million women, with higher rates observed among Hispanic and Asian women.[5][26] Incidence is most common between the ages of 40 and 50, prior to the onset of [menopause](Menopause \"Menopause\").[5] Phyllodes tumors typically present about 15 years later than [fibroadenoma](Fibroadenoma \"Fibroadenoma\"), a common differential diagnosis.[](https://www.ncbi.nlm.nih.gov/books/NBK541138/) Younger women have a higher chance of having a benign phyllodes tumor, while older women are more likely to have higher-grade tumors.[23]"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761882048866,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ Hasdemir S, Tolunay Ş, Özşen M, Gökgöz MŞ (January 2020). [\\\"Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715). _European Journal of Breast Health_. **16** (1): 32–38\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5152/ejbh.2019.4709](https://doi.org/10.5152%2Fejbh.2019.4709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6939715](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31912011](https://pubmed.ncbi.nlm.nih.gov/31912011).\",\"description\":\"1. ^ _**a**_ _**b**_ Hasdemir S, Tolunay Ş, Özşen M, Gökgöz MŞ (January 2020). [\\\"Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715). _European Journal of Breast Health_. **16** (1): 32–38\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.5152/ejbh.2019.4709](https://doi.org/10.5152%2Fejbh.2019.4709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6939715](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31912011](https://pubmed.ncbi.nlm.nih.gov/31912011).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939715\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ Konstantakos AK, Graham DJ (September 2003). \\\"Cystosarcoma phyllodes tumors in men\\\". _The American Surgeon_. **69** (9): 808–811\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/000313480306900916](https://doi.org/10.1177%2F000313480306900916). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14509333](https://pubmed.ncbi.nlm.nih.gov/14509333). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26206134](https://api.semanticscholar.org/CorpusID:26206134).\",\"description\":\"2. ^ _**a**_ _**b**_ Konstantakos AK, Graham DJ (September 2003). \\\"Cystosarcoma phyllodes tumors in men\\\". _The American Surgeon_. **69** (9): 808–811\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/000313480306900916](https://doi.org/10.1177%2F000313480306900916). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14509333](https://pubmed.ncbi.nlm.nih.gov/14509333). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26206134](https://api.semanticscholar.org/CorpusID:26206134).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"_**a**_ _**b**_ Zhou ZR, Wang CC, Yang ZZ, Yu XL, Guo XM (November 2016). [\\\"Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374). _Journal of Thoracic Disease_. **8** (11): 3361–3368\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.21037/jtd.2016.11.03](https://doi.org/10.21037%2Fjtd.2016.11.03). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5179374](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28066617](https://pubmed.ncbi.nlm.nih.gov/28066617).\",\"description\":\"3. ^ _**a**_ _**b**_ Zhou ZR, Wang CC, Yang ZZ, Yu XL, Guo XM (November 2016). [\\\"Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374). _Journal of Thoracic Disease_. **8** (11): 3361–3368\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.21037/jtd.2016.11.03](https://doi.org/10.21037%2Fjtd.2016.11.03). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5179374](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28066617](https://pubmed.ncbi.nlm.nih.gov/28066617).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179374\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H (September 2003). [\\\"Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma\\\"](https://doi.org/10.1001%2Farchsurg.138.9.987). _Archives of Surgery_. **138** (9): 987–990\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archsurg.138.9.987](https://doi.org/10.1001%2Farchsurg.138.9.987). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12963656](https://pubmed.ncbi.nlm.nih.gov/12963656).\",\"description\":\"4. **^** Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H (September 2003). [\\\"Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma\\\"](https://doi.org/10.1001%2Farchsurg.138.9.987). _Archives of Surgery_. **138** (9): 987–990\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archsurg.138.9.987](https://doi.org/10.1001%2Farchsurg.138.9.987). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12963656](https://pubmed.ncbi.nlm.nih.gov/12963656).\",\"url\":\"https://doi.org/10.1001%2Farchsurg.138.9.987\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ Limaiem F, Kashyap S (2022). [_Phyllodes Tumor Of The Breast_](https://www.ncbi.nlm.nih.gov/books/NBK541138/). Treasure Island (FL): StatPearls Publishing. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31082182](https://pubmed.ncbi.nlm.nih.gov/31082182). Retrieved 2023-01-18. `{{cite book}}`: `|work=` ignored (help)\",\"description\":\"5. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ Limaiem F, Kashyap S (2022). [_Phyllodes Tumor Of The Breast_](https://www.ncbi.nlm.nih.gov/books/NBK541138/). Treasure Island (FL): StatPearls Publishing. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31082182](https://pubmed.ncbi.nlm.nih.gov/31082182). Retrieved 2023-01-18. `{{cite book}}`: `|work=` ignored (help)\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK541138/\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"** Khan SA, Badve S (April 2001). \\\"Phyllodes tumors of the breast\\\". _Current Treatment Options in Oncology_. **2** (2): 139–147\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s11864-001-0056-y](https://doi.org/10.1007%2Fs11864-001-0056-y). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12057132](https://pubmed.ncbi.nlm.nih.gov/12057132). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34616186](https://api.semanticscholar.org/CorpusID:34616186).\",\"description\":\"6. **^** Khan SA, Badve S (April 2001). \\\"Phyllodes tumors of the breast\\\". _Current Treatment Options in Oncology_. **2** (2): 139–147\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s11864-001-0056-y](https://doi.org/10.1007%2Fs11864-001-0056-y). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12057132](https://pubmed.ncbi.nlm.nih.gov/12057132). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34616186](https://api.semanticscholar.org/CorpusID:34616186).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. (February 2008). \\\"Phyllodes tumor of the breast\\\". _International Journal of Radiation Oncology, Biology, Physics_. **70** (2): 492–500\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ijrobp.2007.06.059](https://doi.org/10.1016%2Fj.ijrobp.2007.06.059). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17931796](https://pubmed.ncbi.nlm.nih.gov/17931796).\",\"description\":\"7. **^** Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. (February 2008). \\\"Phyllodes tumor of the breast\\\". _International Journal of Radiation Oncology, Biology, Physics_. **70** (2): 492–500\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ijrobp.2007.06.059](https://doi.org/10.1016%2Fj.ijrobp.2007.06.059). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17931796](https://pubmed.ncbi.nlm.nih.gov/17931796).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ _**c**_ Hartmann TC, Hanna MW (October 2022). [\\\"Delayed Conversion of a Fibroadenoma Into a Large Phyllodes Tumor: A Case Report\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494). _Cureus_. **14** (10): e30795. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7759/cureus.30795](https://doi.org/10.7759%2Fcureus.30795). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9701494](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36447717](https://pubmed.ncbi.nlm.nih.gov/36447717).\",\"description\":\"8. ^ _**a**_ _**b**_ _**c**_ Hartmann TC, Hanna MW (October 2022). [\\\"Delayed Conversion of a Fibroadenoma Into a Large Phyllodes Tumor: A Case Report\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494). _Cureus_. **14** (10): e30795. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7759/cureus.30795](https://doi.org/10.7759%2Fcureus.30795). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9701494](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36447717](https://pubmed.ncbi.nlm.nih.gov/36447717).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ Karim, Rooshdiya Z.; Scolyer, Richard A.; Tse, Gary M.; Tan, Puay-Hoon; Putti, Thomas C.; Lee, C. Soon (February 2009). \\\"Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours\\\". _Pathology_. **41** (2): 105–117\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00313020802579342](https://doi.org/10.1080%2F00313020802579342). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-3025](https://search.worldcat.org/issn/0031-3025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19152185](https://pubmed.ncbi.nlm.nih.gov/19152185). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34470088](https://api.semanticscholar.org/CorpusID:34470088).\",\"description\":\"9. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ Karim, Rooshdiya Z.; Scolyer, Richard A.; Tse, Gary M.; Tan, Puay-Hoon; Putti, Thomas C.; Lee, C. Soon (February 2009). \\\"Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours\\\". _Pathology_. **41** (2): 105–117\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/00313020802579342](https://doi.org/10.1080%2F00313020802579342). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-3025](https://search.worldcat.org/issn/0031-3025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19152185](https://pubmed.ncbi.nlm.nih.gov/19152185). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [34470088](https://api.semanticscholar.org/CorpusID:34470088).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"_**a**_ _**b**_ Sim, Yirong; Ng, Gwendolene Xin Pei; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Wong, Suet Far; Liu, Wei; Guan, Peiyong; Nagarajan, Sanjanaa; Ng, Wai Yee; Thike, Aye Aye; Lim, Jeffrey Chun Tatt; Nasir, Nur Diyana Binte Md; Tan, Veronique Kiak Mien; Madhukumar, Preetha; Yong, Wei Sean (2019-10-23). [\\\"A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086). _BMC Medical Genomics_. **12** (1): 142. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/s12920-019-0588-2](https://doi.org/10.1186%2Fs12920-019-0588-2). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1755-8794](https://search.worldcat.org/issn/1755-8794). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6813086](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31647027](https://pubmed.ncbi.nlm.nih.gov/31647027).\",\"description\":\"10. ^ _**a**_ _**b**_ Sim, Yirong; Ng, Gwendolene Xin Pei; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Wong, Suet Far; Liu, Wei; Guan, Peiyong; Nagarajan, Sanjanaa; Ng, Wai Yee; Thike, Aye Aye; Lim, Jeffrey Chun Tatt; Nasir, Nur Diyana Binte Md; Tan, Veronique Kiak Mien; Madhukumar, Preetha; Yong, Wei Sean (2019-10-23). [\\\"A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086). _BMC Medical Genomics_. **12** (1): 142. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/s12920-019-0588-2](https://doi.org/10.1186%2Fs12920-019-0588-2). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1755-8794](https://search.worldcat.org/issn/1755-8794). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6813086](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31647027](https://pubmed.ncbi.nlm.nih.gov/31647027).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813086\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Boutas, Ioannis; Kontogeorgi, Adamandia; Dimas, Dionysios; Koufopoulos, Nektarios; Genitsaridi, Sofia-Maria; Sitara, Kyparissia; Kalantaridou, Sophia; Dimitrakakis, Constantine (October 2022). [\\\"Local recurrence for phyllodes tumours of the breast: Systematic review and meta-analysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605). _Oncology Letters_. **24** (4): 353. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3892/ol.2022.13473](https://doi.org/10.3892%2Fol.2022.13473). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1792-1082](https://search.worldcat.org/issn/1792-1082). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9478605](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36168312](https://pubmed.ncbi.nlm.nih.gov/36168312).\",\"description\":\"11. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Boutas, Ioannis; Kontogeorgi, Adamandia; Dimas, Dionysios; Koufopoulos, Nektarios; Genitsaridi, Sofia-Maria; Sitara, Kyparissia; Kalantaridou, Sophia; Dimitrakakis, Constantine (October 2022). [\\\"Local recurrence for phyllodes tumours of the breast: Systematic review and meta-analysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605). _Oncology Letters_. **24** (4): 353. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3892/ol.2022.13473](https://doi.org/10.3892%2Fol.2022.13473). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1792-1082](https://search.worldcat.org/issn/1792-1082). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9478605](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36168312](https://pubmed.ncbi.nlm.nih.gov/36168312).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478605\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Macdonald, O. Kenneth; Lee, Christopher M.; Tward, Jonathan D.; Chappel, Craig D.; Gaffney, David K. (2006-11-01). [\\\"Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program\\\"](https://doi.org/10.1002%2Fcncr.22228). _Cancer_. **107** (9): 2127–2133\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cncr.22228](https://doi.org/10.1002%2Fcncr.22228). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16998937](https://pubmed.ncbi.nlm.nih.gov/16998937). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [35411155](https://api.semanticscholar.org/CorpusID:35411155).\",\"description\":\"12. **^** Macdonald, O. Kenneth; Lee, Christopher M.; Tward, Jonathan D.; Chappel, Craig D.; Gaffney, David K. (2006-11-01). [\\\"Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program\\\"](https://doi.org/10.1002%2Fcncr.22228). _Cancer_. **107** (9): 2127–2133\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cncr.22228](https://doi.org/10.1002%2Fcncr.22228). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16998937](https://pubmed.ncbi.nlm.nih.gov/16998937). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [35411155](https://api.semanticscholar.org/CorpusID:35411155).\",\"url\":\"https://doi.org/10.1002%2Fcncr.22228\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** [\\\"UpToDate\\\"](https://www.uptodate.com/contents/phyllodes-tumors-of-the-breast). _www.uptodate.com_. Retrieved 2023-01-26.\",\"description\":\"13. **^** [\\\"UpToDate\\\"](https://www.uptodate.com/contents/phyllodes-tumors-of-the-breast). _www.uptodate.com_. Retrieved 2023-01-26.\",\"url\":\"https://www.uptodate.com/contents/phyllodes-tumors-of-the-breast\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"_**a**_ _**b**_ Deen SA, McKee GT, Kissin MW (February 1999). \\\"Differential cytologic features of fibroepithelial lesions of the breast\\\". _Diagnostic Cytopathology_. **20** (2): 53–56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/(SICI)1097-0339(199902)20:2\u003c53::AID-DC1\u003e3.0.CO;2-T](https://doi.org/10.1002%2F%28SICI%291097-0339%28199902%2920%3A2%3C53%3A%3AAID-DC1%3E3.0.CO%3B2-T). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9951596](https://pubmed.ncbi.nlm.nih.gov/9951596). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21831164](https://api.semanticscholar.org/CorpusID:21831164).\",\"description\":\"14. ^ _**a**_ _**b**_ Deen SA, McKee GT, Kissin MW (February 1999). \\\"Differential cytologic features of fibroepithelial lesions of the breast\\\". _Diagnostic Cytopathology_. **20** (2): 53–56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/(SICI)1097-0339(199902)20:2\u003c53::AID-DC1\u003e3.0.CO;2-T](https://doi.org/10.1002%2F%28SICI%291097-0339%28199902%2920%3A2%3C53%3A%3AAID-DC1%3E3.0.CO%3B2-T). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9951596](https://pubmed.ncbi.nlm.nih.gov/9951596). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21831164](https://api.semanticscholar.org/CorpusID:21831164).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. (January 2016). [\\\"Phyllodes tumours of the breast: a consensus review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876). _Histopathology_. **68** (1): 5–21\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/his.12876](https://doi.org/10.1111%2Fhis.12876). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5027876](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26768026](https://pubmed.ncbi.nlm.nih.gov/26768026).\",\"description\":\"15. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. (January 2016). [\\\"Phyllodes tumours of the breast: a consensus review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876). _Histopathology_. **68** (1): 5–21\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/his.12876](https://doi.org/10.1111%2Fhis.12876). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5027876](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26768026](https://pubmed.ncbi.nlm.nih.gov/26768026).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027876\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"_**a**_ _**b**_ _**c**_ Majeski, James; Stroud, Jason (2012). [\\\"Malignant phyllodes tumors of the breast: a study in clinical practice\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204). _International Surgery_. **97** (2): 95–98\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.9738/CC79.1](https://doi.org/10.9738%2FCC79.1). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2520-2456](https://search.worldcat.org/issn/2520-2456). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3723204](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23102073](https://pubmed.ncbi.nlm.nih.gov/23102073).\",\"description\":\"16. ^ _**a**_ _**b**_ _**c**_ Majeski, James; Stroud, Jason (2012). [\\\"Malignant phyllodes tumors of the breast: a study in clinical practice\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204). _International Surgery_. **97** (2): 95–98\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.9738/CC79.1](https://doi.org/10.9738%2FCC79.1). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2520-2456](https://search.worldcat.org/issn/2520-2456). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3723204](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23102073](https://pubmed.ncbi.nlm.nih.gov/23102073).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723204\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Khanal, Suman; Singh, Yogendra P.; Bhandari, Anuja; Sharma, Rashmi (December 2018). [\\\"Malignant phyllodes tumor with metastases to lung, adrenal and brain: A rare case report\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230968). _Annals of Medicine and Surgery_. **36** : 113–117\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amsu.2018.10.030](https://doi.org/10.1016%2Fj.amsu.2018.10.030). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2049-0801](https://search.worldcat.org/issn/2049-0801). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6230968](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30455875](https://pubmed.ncbi.nlm.nih.gov/30455875).\",\"description\":\"17. **^** Khanal, Suman; Singh, Yogendra P.; Bhandari, Anuja; Sharma, Rashmi (December 2018). [\\\"Malignant phyllodes tumor with metastases to lung, adrenal and brain: A rare case report\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230968). _Annals of Medicine and Surgery_. **36** : 113–117\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amsu.2018.10.030](https://doi.org/10.1016%2Fj.amsu.2018.10.030). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2049-0801](https://search.worldcat.org/issn/2049-0801). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6230968](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30455875](https://pubmed.ncbi.nlm.nih.gov/30455875).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230968\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** Zhang, John Z.; Gu, Mai (2003). \\\"Malignant phyllodes tumor of the breast metastatic to the parotid gland diagnosed by fine needle aspiration biopsy. A case report\\\". _Acta Cytologica_. **47** (2): 253–258\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000326512](https://doi.org/10.1159%2F000326512). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0001-5547](https://search.worldcat.org/issn/0001-5547). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12685197](https://pubmed.ncbi.nlm.nih.gov/12685197). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [3364081](https://api.semanticscholar.org/CorpusID:3364081).\",\"description\":\"18. **^** Zhang, John Z.; Gu, Mai (2003). \\\"Malignant phyllodes tumor of the breast metastatic to the parotid gland diagnosed by fine needle aspiration biopsy. A case report\\\". _Acta Cytologica_. **47** (2): 253–258\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000326512](https://doi.org/10.1159%2F000326512). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0001-5547](https://search.worldcat.org/issn/0001-5547). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12685197](https://pubmed.ncbi.nlm.nih.gov/12685197). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [3364081](https://api.semanticscholar.org/CorpusID:3364081).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Makhija D, Shah H, Bothra J, Jayaswal S (December 2016). [\\\"An adolescent with a phyllodes tumor: A case report and review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372421). _International Journal of Pediatrics \u0026 Adolescent Medicine_. **3** (4): 180–183\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ijpam.2016.03.005](https://doi.org/10.1016%2Fj.ijpam.2016.03.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6372421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30805490](https://pubmed.ncbi.nlm.nih.gov/30805490).\",\"description\":\"19. **^** Makhija D, Shah H, Bothra J, Jayaswal S (December 2016). [\\\"An adolescent with a phyllodes tumor: A case report and review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372421). _International Journal of Pediatrics \u0026 Adolescent Medicine_. **3** (4): 180–183\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ijpam.2016.03.005](https://doi.org/10.1016%2Fj.ijpam.2016.03.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6372421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30805490](https://pubmed.ncbi.nlm.nih.gov/30805490).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372421\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"_**a**_ _**b**_ Patel, Shreyaskumar R.; Zagars, Gunar K.; Pisters, Peter W. T. (June 2003). \\\"The follow-up of adult soft-tissue sarcomas\\\". _Seminars in Oncology_. **30** (3): 413–416\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0093-7754(03)00101-5](https://doi.org/10.1016%2Fs0093-7754%2803%2900101-5). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0093-7754](https://search.worldcat.org/issn/0093-7754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12870143](https://pubmed.ncbi.nlm.nih.gov/12870143).\",\"description\":\"20. ^ _**a**_ _**b**_ Patel, Shreyaskumar R.; Zagars, Gunar K.; Pisters, Peter W. T. (June 2003). \\\"The follow-up of adult soft-tissue sarcomas\\\". _Seminars in Oncology_. **30** (3): 413–416\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0093-7754(03)00101-5](https://doi.org/10.1016%2Fs0093-7754%2803%2900101-5). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0093-7754](https://search.worldcat.org/issn/0093-7754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12870143](https://pubmed.ncbi.nlm.nih.gov/12870143).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Grabowski, Julia; Salzstein, Sidney L.; Sadler, Georgia R.; Blair, Sarah L. (October 2007). [\\\"Malignant phyllodes tumors: a review of 752 cases\\\"](https://doi.org/10.1177%2F000313480707301007). _The American Surgeon_. **73** (10): 967–969\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/000313480707301007](https://doi.org/10.1177%2F000313480707301007). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0003-1348](https://search.worldcat.org/issn/0003-1348). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17983058](https://pubmed.ncbi.nlm.nih.gov/17983058). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20319387](https://api.semanticscholar.org/CorpusID:20319387).\",\"description\":\"21. **^** Grabowski, Julia; Salzstein, Sidney L.; Sadler, Georgia R.; Blair, Sarah L. (October 2007). [\\\"Malignant phyllodes tumors: a review of 752 cases\\\"](https://doi.org/10.1177%2F000313480707301007). _The American Surgeon_. **73** (10): 967–969\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/000313480707301007](https://doi.org/10.1177%2F000313480707301007). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0003-1348](https://search.worldcat.org/issn/0003-1348). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17983058](https://pubmed.ncbi.nlm.nih.gov/17983058). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20319387](https://api.semanticscholar.org/CorpusID:20319387).\",\"url\":\"https://doi.org/10.1177%2F000313480707301007\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** [\\\"Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce\\\"](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening). _www.uspreventiveservicestaskforce.org_. Retrieved 2023-01-23.\",\"description\":\"22. **^** [\\\"Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce\\\"](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening). _www.uspreventiveservicestaskforce.org_. Retrieved 2023-01-23.\",\"url\":\"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"_**a**_ _**b**_ Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. (2011). [\\\"Management of phyllodes breast tumors\\\"](https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x). _The Breast Journal_. **17** (2): 129–137\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1524-4741.2010.01045.x](https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21251125](https://pubmed.ncbi.nlm.nih.gov/21251125). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7074922](https://api.semanticscholar.org/CorpusID:7074922).\",\"description\":\"23. ^ _**a**_ _**b**_ Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. (2011). [\\\"Management of phyllodes breast tumors\\\"](https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x). _The Breast Journal_. **17** (2): 129–137\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1524-4741.2010.01045.x](https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21251125](https://pubmed.ncbi.nlm.nih.gov/21251125). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7074922](https://api.semanticscholar.org/CorpusID:7074922).\",\"url\":\"https://doi.org/10.1111%2Fj.1524-4741.2010.01045.x\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Barth RJ, Wells WA, Mitchell SE, Cole BF (August 2009). [\\\"A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421). _Annals of Surgical Oncology_. **16** (8): 2288–2294\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1245/s10434-009-0489-2](https://doi.org/10.1245%2Fs10434-009-0489-2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5053421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19424757](https://pubmed.ncbi.nlm.nih.gov/19424757).\",\"description\":\"24. **^** Barth RJ, Wells WA, Mitchell SE, Cole BF (August 2009). [\\\"A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421). _Annals of Surgical Oncology_. **16** (8): 2288–2294\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1245/s10434-009-0489-2](https://doi.org/10.1245%2Fs10434-009-0489-2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5053421](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19424757](https://pubmed.ncbi.nlm.nih.gov/19424757).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053421\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"_**a**_ _**b**_ Reinfuss, M.; Mituś, J.; Duda, K.; Stelmach, A.; Ryś, J.; Smolak, K. (1996-03-01). [\\\"The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases\\\"](https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6). _Cancer_. **77** (5): 910–916\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/(sici)1097-0142(19960301)77:5\u003c910::aid-cncr16\u003e3.0.co;2-6](https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8608483](https://pubmed.ncbi.nlm.nih.gov/8608483). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [46154369](https://api.semanticscholar.org/CorpusID:46154369).\",\"description\":\"25. ^ _**a**_ _**b**_ Reinfuss, M.; Mituś, J.; Duda, K.; Stelmach, A.; Ryś, J.; Smolak, K. (1996-03-01). [\\\"The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases\\\"](https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6). _Cancer_. **77** (5): 910–916\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/(sici)1097-0142(19960301)77:5\u003c910::aid-cncr16\u003e3.0.co;2-6](https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8608483](https://pubmed.ncbi.nlm.nih.gov/8608483). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [46154369](https://api.semanticscholar.org/CorpusID:46154369).\",\"url\":\"https://doi.org/10.1002%2F%28sici%291097-0142%2819960301%2977%3A5%3C910%3A%3Aaid-cncr16%3E3.0.co%3B2-6\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"_**a**_ _**b**_ Bernstein, L.; Deapen, D.; Ross, R. K. (1993-05-15). [\\\"The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast\\\"](https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g). _Cancer_. **71** (10): 3020–3024\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(19930515)71:10\u003c3020::aid-cncr2820711022\u003e3.0.co;2-g](https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8387873](https://pubmed.ncbi.nlm.nih.gov/8387873). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21014296](https://api.semanticscholar.org/CorpusID:21014296).\",\"description\":\"26. ^ _**a**_ _**b**_ Bernstein, L.; Deapen, D.; Ross, R. K. (1993-05-15). [\\\"The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast\\\"](https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g). _Cancer_. **71** (10): 3020–3024\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(19930515)71:10\u003c3020::aid-cncr2820711022\u003e3.0.co;2-g](https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0008-543X](https://search.worldcat.org/issn/0008-543X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8387873](https://pubmed.ncbi.nlm.nih.gov/8387873). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [21014296](https://api.semanticscholar.org/CorpusID:21014296).\",\"url\":\"https://doi.org/10.1002%2F1097-0142%2819930515%2971%3A10%3C3020%3A%3Aaid-cncr2820711022%3E3.0.co%3B2-g\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"Diagnosis is made via a core-needle biopsy and treatment is typically surgical resection with wide margins (\u003e1 cm), due to their propensity to recur.[4]\\\"\",\"explanation\":\"Reference [4] discusses core needle biopsy for differentiating phyllodes tumor from fibroadenoma but does not address treatment or surgical margins. The citation does not support the treatment claim, potentially misleading on standard care.\",\"fixedText\":\"Retain the diagnosis part with [4]; move or cite treatment separately using an appropriate reference like [5] or [23] for surgical resection.\",\"evidenceSource\":\"Ref 4: Komenaka IK et al. (2003), Archives of Surgery\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"\\\"that form from the periductal stromal and epithelial cells of the breast\\\"\",\"explanation\":\"Phyllodes tumors are fibroepithelial with a neoplastic stromal component (periductal origin) and reactive, non-neoplastic epithelial component. Claiming formation from both implies dual neoplastic origin, which is inaccurate; epithelial cells are not the primary neoplastic source.\",\"fixedText\":\"Revise to: \\\"characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic, arising from periductal stromal cells.\\\"\",\"evidenceSource\":\"Ref 5: Limaiem F et al. (2022), StatPearls; also confirmed in pathology literature (e.g., stromal monoclonality).\"},{\"criticality\":\"Critical\",\"issueType\":\"Other (Factual Inaccuracy in Terminology)\",\"problematicText\":\"\\\"_phullon_\\\" (appears twice)\",\"explanation\":\"The Greek word is \\\"phyllon\\\" (φύλλον), meaning leaf. \\\"Phullon\\\" is a misspelling that inaccurately represents the etymology, potentially confusing readers on linguistic origins.\",\"fixedText\":\"Correct to \\\"_phyllon_\\\" throughout.\",\"evidenceSource\":\"Standard etymology sources (e.g., Radiopaedia, StatPearls); Greek: phyllon = leaf.\"},{\"criticality\":\"Critical\",\"issueType\":\"Figures/Tables/Data Presentation\",\"problematicText\":\"\\\"Pyllodes tumor --- ![](./_assets_/Brachychiton_acerifolius_-_leaf_of_mature_tree_SF21001.jpg)__Phullon__ means 'leaf' in Greek.\\\"\",\"explanation\":\"Misspelled title, extraneous table separator (\\\"---\\\"), and non-medical leaf image with redundant etymology explanation disrupt professional presentation and repeat content already in the main text, confusing the intro structure.\",\"fixedText\":\"Remove misspelled subheader, \\\"---\\\", leaf image, and redundant etymology; retain only the micrograph image and its caption.\",\"evidenceSource\":\"Intro guidance: Remove table parts except images/captions; maintain encyclopedic tone.\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[None - gap in overview]\",\"explanation\":\"\",\"fixedText\":\"Add: \\\"Phyllodes tumors are classified as benign, borderline, or malignant based on histologic features.\\\"\",\"evidenceSource\":\"Ref 5: Limaiem F et al. (2022); standard in overviews (e.g., UpToDate ref 13).\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Genetically, phyllodes tumors have shown to have a higher incidence with conditions such as [Li-Fraumeni syndrome](Li%E2%80%93Fraumeni_syndrome \\\"Li–Fraumeni syndrome\\\") and _[BRCA1](BRCA1 \\\"BRCA1\\\")_ /_[BRCA2](BRCA2 \\\"BRCA2\\\")_ mutations.[5]\",\"explanation\":\"The cited source [5] (StatPearls article) mentions Li-Fraumeni syndrome but does not discuss BRCA1 or BRCA2 mutations at all. Additionally, while rare germline BRCA1 mutations have been reported in some phyllodes tumor cases, there is no established evidence of higher incidence for BRCA1/BRCA2 as risk factors; associations are anecdotal and not recognized as primary genetic predispositions, especially for BRCA2 where evidence is limited to somatic mutations.\",\"fixedText\":\"Retain the mention of Li-Fraumeni syndrome with citation [5], but remove the reference to BRCA1/BRCA2 mutations as it is unsupported by the source and not critically established in literature.\",\"evidenceSource\":\"[5] and web search results indicating insufficient evidence for BRCA1/BRCA2 as risk factors (e.g., 2020 review stating only Li-Fraumeni as known predisposing factor)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; entire section lacks detail on potential origins.\",\"explanation\":\"The section on causes is incomplete, omitting key proposed etiologic theories such as progression from preexisting fibroadenomas and possible influences of hormonal factors (e.g., estrogen, pregnancy, lactation), which are discussed in authoritative sources like StatPearls [5] and other reviews. This creates a knowledge gap in understanding potential precursors and triggers for the tumor.\",\"fixedText\":\"Add sourced information on progression from fibroadenomas and hormonal influences to fill the gap, ensuring no duplication with the Mechanism section (which likely covers stromal/epithelial interactions).\",\"evidenceSource\":\"[5] (StatPearls: \\\"Some authors have suggested that phyllodes tumors may represent a progression from fibroadenoma\\\"; possible stimulation by trauma, pregnancy, increased estrogen activity, lactation)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"In the [Wnt pathway](Wnt_signaling_pathway \\\"Wnt signaling pathway\\\"), gene transcription via [B-catenin](Catenin_beta-1 \\\"Catenin beta-1\\\") is a highly regulated process by proteins including, but not limited to, _c-myc_ , _c_ -_jun_ , _Fra_ , and c _yclin D1_.[9] Mutation of any these proteins can lead to the un-regulated, rapid growth characteristic of phyllodes tumors.[9]\",\"explanation\":\"The description incorrectly states that beta-catenin-mediated gene transcription is regulated by downstream targets like c-myc, c-jun, Fra-1, and cyclin D1. In the Wnt pathway, stabilized beta-catenin activates transcription of these target genes, which then drive proliferation. Mutations typically occur in upstream components (e.g., APC, CTNNB1 encoding beta-catenin), leading to pathway hyperactivation and unregulated growth.\",\"fixedText\":\"Rewrite to clarify: Stabilized beta-catenin enters the nucleus and promotes transcription of target genes such as c-myc, c-jun, Fra-1, and cyclin D1, which contribute to cell proliferation. Dysregulation of the Wnt pathway, often through mutations in components like APC or beta-catenin, results in uncontrolled growth characteristic of phyllodes tumors.\",\"evidenceSource\":\"Standard Wnt signaling mechanism; [](https://www.nature.com/articles/s41392-025-02142-w)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Some theories suggest a genetic cause while other literature supports the involvement of hormone and growth factor receptors, cell signal transduction pathways, and cell cycle markers.[8][9][10]\",\"explanation\":\"Reference [8] is a case report on fibroadenoma-to-phyllodes progression that briefly cites literature on genetic mutations (e.g., MED12) but does not discuss or support involvement of hormone/growth factor receptors, signal transduction pathways, or cell cycle markers.\",\"fixedText\":\"Remove citation [8] from this sentence; retain [9][10].\",\"evidenceSource\":\"[8] [](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701494/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"The current theory behind the development of phyllodes tumors involves the interaction between each of these pathways to some degree and how they alter the normal interaction of the breast epithelial-stromal tissue.[9]\",\"explanation\":\"The term \\\"current theory\\\" is undated and relies on a 2009 reference [9]. As of 2025, genomic studies have advanced understanding, identifying recurrent mutations (e.g., MED12, TERT) and therapeutic targets (e.g., EGFR, PIK3CA), emphasizing stromal clonal expansion and epithelial-stromal interactions.\",\"fixedText\":\"Revise to: Recent studies indicate that phyllodes tumor development arises from dysregulated epithelial-stromal interactions, driven by genetic alterations and pathway activations that promote stromal proliferation. [9][new ref]\",\"evidenceSource\":\"[](https://academic.oup.com/oncolo/article/29/12/1024/7742815) (2024 genomic study)\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"The section omits key recent genomic insights (post-2019), such as high prevalence of MED12 mutations (up to 80% in benign/borderline), TERT promoter mutations (40-60%, associated with malignancy), RARA rearrangements, and additional drivers like EGFR amplification and PIK3CA mutations in malignant cases, which inform pathogenesis and potential targeted therapies.\",\"fixedText\":\"Expand the genes paragraph to include prevalence and associations: Genes frequently mutated in phyllodes tumors include MED12 (exon 2, ~70-80%), TERT promoter (~50%), and RARA (~20-30%), which regulate transcription, telomere maintenance, and differentiation, respectively. Malignant tumors often show additional alterations like EGFR amplification and PIK3CA mutations. [10][new refs]\",\"evidenceSource\":\"[](https://ejbc.kr/DOIx.php?id=10.4048/jbc.2024.0284) (2025 review); [](https://academic.oup.com/oncolo/article/29/12/1024/7742815) (2024)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"Approximately 10% of phyllodes tumor develop distant metastases and this occurrence is higher (20%) in patients with histological-identified malignant tumors.[16]\\\"\",\"explanation\":\"Reference 16 (Majeski \u0026 Stroud, 2012) does not explicitly state these metastasis rates; it mentions recurrence or metastasis up to 27% but lacks the specific 10% overall and 20% for malignant figures. Accurate rates from consensus sources indicate distant metastases in \u0026lt;5% overall (benign ~0%, borderline ~2%, malignant ~17%), not 10% overall.\",\"fixedText\":\"Correct to: \\\"Distant metastases are rare, occurring in less than 5% of cases overall but in approximately 15-20% of malignant cases.\\\" Cite [15] instead of [16].\",\"evidenceSource\":\"[15]\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"Due to their propensity to metastasize and grow quickly, almost all phyllodes tumors are regarded as having malignant potential and treated accordingly.[15]\\\"\",\"explanation\":\"This implies all grades (including benign) have high metastatic propensity, but benign phyllodes tumors rarely metastasize (\u0026lt;1%) and have low malignant potential; metastasis is primarily a feature of malignant grade. Misapplies characteristics of malignant tumors to all.\",\"fixedText\":\"Revise to: \\\"Malignant phyllodes tumors have a propensity to metastasize and are treated with consideration of their sarcomatous potential.\\\" Remove or qualify the \\\"almost all\\\" claim for neutrality and accuracy.\",\"evidenceSource\":\"[15]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"Histopathologic classification[19] | Benign | Borderline | Malignant\\\" (entire table)\",\"explanation\":\"Reference 19 (Makhija et al., 2016) is a case report with a table showing borderline mitoses as \u0026lt;10 (not 5-9), and lacks full criteria alignment with WHO consensus. The input table uses standard criteria (e.g., 5-9 mitoses for borderline) but cites an mismatched source; table is also incomplete (blanks for borderline margin and malignant overgrowth).\",\"fixedText\":\"Update citation to [15]. Complete table per WHO consensus: Borderline margin \\\"Pushing or irregular\\\"; stromal overgrowth \\\"Focal\\\" for borderline and \\\"Present\\\" for malignant. Adjust mitoses to ≤4/\u0026lt;5 for benign if precise, but retain approximate.\",\"evidenceSource\":\"[15]\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"None (general gap in diagnostic techniques subsection)\",\"explanation\":\"The section lacks mention of the limitations of fine-needle aspiration (FNA), which is less accurate than core biopsy for distinguishing phyllodes from fibroadenoma due to overlapping cytologic features, a key diagnostic challenge supported by references.\",\"fixedText\":\"Add: \\\"Fine-needle aspiration is less reliable for definitive diagnosis due to cytologic overlap with fibroadenoma and is not recommended as the sole method.\\\" Cite [4] or [14].\",\"evidenceSource\":\"[4], [14]\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Patients who have not had a mastectomy should continue regular breast cancer screening based on the recommendations by the United States Preventative Services Task Force.[22]\",\"explanation\":\"The cited USPSTF recommendation was retrieved in 2023, but USPSTF updated its breast cancer screening guidelines in April 2024 to recommend biennial screening starting at age 40 through 74 for average-risk women, expanding from the previous 2016 guidelines starting at age 50. This change affects the accuracy of \\\"regular breast cancer screening\\\" guidance for patients post-phyllodes tumor treatment who retain breast tissue, as it could influence screening start age and frequency.\",\"fixedText\":\"Update the citation to the current USPSTF guidelines (as of 2024) and correct the spelling to \\\"Preventive Services Task Force\\\". Specify that screening follows current USPSTF recommendations for average-risk women (biennial mammograms from age 40 to 74).\",\"evidenceSource\":\"[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"There is no evidence-based recommendations for screening or preventative measures for early detection of phyllodes tumors.[20][21]\",\"explanation\":\"References [20] and [21] discuss follow-up and prognosis but do not explicitly state or provide evidence for the absence of evidence-based screening or preventive measures for phyllodes tumors. While the claim is likely accurate due to the rarity of the condition, the citations do not directly support it, potentially misleading verifiability.\",\"fixedText\":\"Add a new authoritative citation (e.g., NCCN or recent review) that confirms no specific screening recommendations exist for phyllodes tumors due to their rarity and lack of identifiable risk factors.\",\"evidenceSource\":\"Existing ref #20 and #21; confirmed via content extraction showing no mention of screening/prevention.\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[None - overall section]\",\"explanation\":\"The section lacks details on current follow-up surveillance protocols post-treatment, such as frequency of clinical exams and imaging, which vary by tumor grade (e.g., every 6-12 months for high-risk cases). This is a knowledge gap, as recent guidelines (e.g., NCCN 2024) provide more specific recommendations for monitoring recurrence.\",\"fixedText\":\"Expand the follow-up paragraph to include standard surveillance based on risk stratification, citing recent guidelines.\",\"evidenceSource\":\"[](https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"A study performed in 2012 derived a risk calculator for relapse risk of phyllodes tumors after surgery.[25]\\\"\",\"explanation\":\"Reference [25] is a 1996 study analyzing treatment and prognosis in 170 cases, which does not mention deriving a risk calculator. No evidence of a 2012 study creating such a calculator was found in searches of peer-reviewed literature.\",\"fixedText\":\"Remove the entire sentence as it is unsupported and erroneous.\",\"evidenceSource\":\"Ref [25]; web search results confirming no 2012 study\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"The most common, curative treatment for a phyllodes tumor is wide surgical excision with greater than 1 cm margins.[15]\\\"\",\"explanation\":\"The recommendation for \u003e1 cm margins is traditional but not universally applied across all grades (benign, borderline, malignant). Recent guidelines (e.g., NCCN 2021 update) recommend excision without specific margins for benign tumors, and there is ongoing debate/lack of consensus for optimal margins in borderline/malignant cases, potentially leading to overtreatment if presented as standard for all.\",\"fixedText\":\"Revise to specify variation by tumor grade: wide excision aiming for negative margins (≥1 cm traditionally recommended for borderline/malignant); for benign, negative margins may suffice without wide excision.\",\"evidenceSource\":\"Ref [15]; NCCN guidelines (2021 update) via https://www.nccn.org/guidelines/guidelines-detail?id=1419\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"Treatment recommendations differ by histologic grade (benign, borderline, malignant), which is not addressed. This gap affects applicability, as benign tumors may not require wide margins, while malignant may benefit from adjuvant radiation. Recent developments (as of 2025) include emerging roles for targeted therapies in malignant cases.\",\"fixedText\":\"Add differentiation by grade in treatment description; briefly note adjuvant options for higher grades and emerging targeted therapies for malignant (as of 2025).\",\"evidenceSource\":\"Refs [15], [24]; UK Association of Breast Surgery guidelines (2025) via https://associationofbreastsurgery.org.uk/professionals/information-hub/guidelines/2025/contemporary-management-of-phyllodes-tumours-of-the-breast-recommendations-from-the-uk-association-of-breast-surgery; Duke Cancer Institute research (2025) via https://www.dukecancerinstitute.org/blogs/new-research-supports-use-targeted-therapies-malignant-phyllodes-tumors-breast-cancer\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"The section discusses overall survival and cure rates for benign and borderline tumors but omits specific recurrence and survival details for malignant tumors beyond metastasis.\",\"explanation\":\"Phyllodes tumors are graded as benign, borderline, or malignant, with varying prognoses. Omitting grade-specific recurrence rates and malignant outcomes creates a knowledge gap, as malignant cases have higher risks that impact overall understanding of prognosis.\",\"fixedText\":\"Add grade-specific local recurrence rates from ref [5]: 10–17% for benign, 14–25% for borderline, and 23–30% for malignant. Note that metastasis is rare overall (\u0026lt;5%) but occurs almost exclusively in malignant cases, leading to poor prognosis when present.\",\"evidenceSource\":\"[5]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Phyllodes tumors account for approximately 1% of all breast neoplasms.[2]\",\"explanation\":\"The cited source [2] explicitly states that phyllodes tumors comprise less than 0.3% of all breast neoplasms, not approximately 1%. This is a significant misrepresentation of the source's supported claim.\",\"fixedText\":\"Revise the claim to \\\"less than 1%\\\" to align with the source and broader literature (e.g., 0.3-1%).\",\"evidenceSource\":\"[2]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Incidence is most common between the ages of 40 and 50, prior to the onset of [menopause](Menopause \\\"Menopause\\\").[26]\",\"explanation\":\"Source [26] describes the epidemiology specifically of malignant phyllodes tumors (peaking at 45-49 years), not all phyllodes tumors. The claim applies to all phyllodes tumors, creating a scope mismatch.\",\"fixedText\":\"Replace citation with [5], which covers all phyllodes tumors and states average age 40-50 years.\",\"evidenceSource\":\"[26]\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"For comparison, this is about 15 years older than the typical age of patients with a [fibroadenoma](Fibroadenoma \\\"Fibroadenoma\\\"), a common differential diagnosis in patients with a suspected phyllodes tumors.[26]\",\"explanation\":\"Source [26] does not mention fibroadenoma, its typical age, or any comparison. The claim is unsupported by the cited reference.\",\"fixedText\":\"Add a new citation for the fibroadenoma age comparison or remove the unsupported comparative detail; retain the differential diagnosis mention as it is standard.\",\"evidenceSource\":\"[26]\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"The section omits key epidemiological details, such as absolute incidence rates (approximately 2.1-2.7 per million women annually) and ethnic disparities (higher incidence in Hispanic and Asian women compared to non-Hispanic white women).\",\"fixedText\":\"Add sentences: \\\"The annual incidence is approximately 2.5 cases per million women. Higher rates are observed among Hispanic and Asian women.\\\"\",\"evidenceSource\":\"[5]; [26]\"}],\"slug\":\"Phyllodes_tumor\",\"title\":\"Phyllodes tumor\",\"content\":\"$1f\",\"description\":\"Phyllodes tumor\\n\\nPhyllodes tumors (from Greek: phyllon, meaning \\\"leaf\\\") are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the...\",\"metadata\":{\"categories\":[\"Cystosarcoma phyllodes\",\"Phyllodes tumour\",\"Phylloides tumor\"],\"lastModified\":\"1761553913\",\"contentLength\":\"11508\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"25683\",\"recentViews\":\"25683\",\"dailyAvgViews\":856.0999755859375,\"qualityScore\":1,\"lastViewed\":\"1761882048\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761882048864,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Phyllodes_tumor\"],\"queryHash\":\"[\\\"page\\\",\\\"Phyllodes_tumor\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Phyllodes tumor\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Phyllodes tumors (from Greek: phyllon, meaning \\\"leaf\\\") are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"Cystosarcoma phyllodes, Phyllodes tumour, Phylloides tumor\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Phyllodes_tumor\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Phyllodes tumor\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Phyllodes tumors (from Greek: phyllon, meaning \\\"leaf\\\") are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Phyllodes_tumor\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Phyllodes tumor\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.913Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Phyllodes tumor\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Phyllodes tumors (from Greek: phyllon, meaning \\\"leaf\\\") are a rare type of biphasic fibroepithelial mass characterized by proliferation of stromal and epithelial components, with the stromal component being neoplastic and arising from periductal stromal cells of the breast.[1][5] They account for less than 1% of all breast neoplasms.[2] They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YmZkMDZjNDQtNTAxZS00OTJkLWI2ZmUtNjQxNjZiMjAwMTVl">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Phyllodes_tumor\"}]}]\n"])</script></body></html>